Evaluating dimensions related to ER (e.g., levels of emotional reactivity) alongside accessible biomarkers such as blood pressure, CRP, and glycaemia, in addition to monitoring mood symptoms in BD patients, may help implement interventions more aligned with the underlying pathophysiology of BD (178). The gene discussed is CRP; the disease is Behcet disease.